Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • The Pharma 50

AstraZeneca announces global R&D postdoctoral program for complex disease research

By Brian Buntz | March 17, 2022

AstraZenecaAstraZeneca (LON:AZN) is looking for final year MD or PhD students and postdoctoral researchers to reach out with ideas to speed drug discovery and development in the company’s core disease areas.

The company’s central focus areas include oncology; cardiovascular, renal and metabolism; and respiratory and immunology.

Candidates accepted into the program have a fully funded postdoctoral research position that gives them access to in-house expertise, access to AstraZeneca’s R&D facilities and support from a partnering university.

Researchers will also get access to compounds, tools and technologies and mentoring.

Sir Mene Pangalos, AstraZeneca’s executive vice president, biopharmaceuticals R&D highlighted the need to continue accelerating R&D. “Rapid progress in disease understanding, as well as scientific and technological advances are genuinely changing our expectations of what is possible,” Pangalos said. “We are delighted to launch the R&D Postdoctoral Challenge to support the next generation of science leaders and help them translate their ideas into meaningful benefits for patients.”

Applicants who are shortlisted will receive an opportunity to pitch research proposals to a judging panel.


Filed Under: Drug Discovery and Development
Tagged With: AstraZeneca, AstraZeneca plc, research
 

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

Lab facility
Massachusetts is competing for ARPA-H biomedical research center
GenScript
GenScript debuts single- and double-strand DNA service for cell and gene therapy development
NIH National Institutes of Health
NIH licenses COVID-19 research technologies to WHO initiative
Janssen
Janssen’s company group chairman dishes on growth strategy

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • The Pharma 50